XML 26 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common stock
ATM sales
Common stock
Follow-on public offering
Common stock
Additional paid-in capital
ATM sales
Additional paid-in capital
Follow-on public offering
Additional paid-in capital
Accumulated deficit
Impact of adoption of ASC 842
Accumulated deficit
Accumulated other comprehensive loss
Impact of adoption of ASC 842
ATM sales
Follow-on public offering
Total
Balance at Mar. 31, 2019     $ 32     $ 198,645   $ (59,766) $ (1,055)       $ 137,856
Balance (in shares) at Mar. 31, 2019     31,656,950                    
Increase (decrease) in Stockholders' Equity                          
Issuance of prefunded warrants to purchase common stock, net of issuance costs           28,145             28,145
Issuance of common stock, net of issuance costs and underwriter fees   $ 5   $ 4,431 $ 57,448           $ 4,431 $ 57,453  
Issuance of common stock, net of issuance costs and underwriter fees (in shares) 287,559 4,516,561                 287,559    
Foreign currency translation adjustment                 (236)       (236)
Unrealized loss on short-term investments, net of tax                 309       309
Exercise of stock options           551             551
Exercise of stock options (in shares)     207,673                    
Stock-based compensation expense           7,741             7,741
Net loss               (52,625)         (52,625)
Balance at Mar. 31, 2020     $ 37     296,961 $ 93 (112,298) (982) $ 93     183,718
Balance (in shares) at Mar. 31, 2020     36,668,743                    
Increase (decrease) in Stockholders' Equity                          
Issuance of prefunded warrants to purchase common stock, net of issuance costs           91,650             91,650
Issuance of common stock, net of issuance costs and underwriter fees     $ 8     286,099             286,107
Issuance of common stock, net of issuance costs and underwriter fees (in shares)     9,103,261                    
Foreign currency translation adjustment                 866       866
Unrealized loss on short-term investments, net of tax                 (278)       (278)
Exercise of stock options     $ 2     5,743             $ 5,745
Exercise of stock options (in shares)     794,477                   794,477
Stock-based compensation expense           11,790             $ 11,790
Net loss               (80,870)         (80,870)
Balance at Mar. 31, 2021     $ 47     $ 692,243   $ (193,168) $ (394)       $ 498,728
Balance (in shares) at Mar. 31, 2021     46,566,481